NLRP3 inhibitors (Chengdu Baiyu Pharmaceutical)

N/A

Report date: 2025/03/20 09:56:23
NME

Base Information

Drug NameNLRP3 inhibitors (Chengdu Baiyu Pharmaceutical)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNACHT, LRR and PYD domains-containing protein 3 inhibitors
TargetsNACHT, LRR and PYD domains-containing protein 3
Therapy Area/IndicationsInflammation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesChengdu Baiyu Pharma Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesChengdu Baiyu Pharma Co Ltd
Inactive CompaniesN/A
Active IndicationsInflammation
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A